Metastatic Breast
Cancer Research Conference

Virtual | September 9-11

A conference with a mission.

Working together to change the odds.

The mission of this medical conference is to bring together a diverse audience to create a collaborative research environment with a long term goal of developing curative approaches for metastatic breast cancer patients.

Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities.  Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice.  Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

About the Conference

The Metastatic Breast Cancer Conference was established in 2014 as an annual medical conference for metastatic breast cancer by Theresa’s Research Foundation with leadership from Dr. Matthew Ellis and Dr. Danny Welch. The specific focus on metastatic disease is based on a major unmet clinical need (incurability); thereby distinguishing this conference from other breast cancer-centered conferences. The first conference was hosted at the University of Kansas Cancer Center. In 2015, 2016 and 2017 the MBCC was hosted at Baylor College of Medicine. The 2018 Conference took place at Johns Hopkins University School of Medicine. The 2019 Conference was held with Mayo Clinic in Scottsdale, Arizona. Additional leadership is provided by Dr. Xiang Zhang and the conference planning committee.

2020 Conference

Activity Director

Alana Welm, PhD

Huntsman Cancer Inst.

Activity Director

Matthew Ellis

MB, BChir, BSc., PhD, FRCP
Baylor College of Medicine

Co-Activity Director

Xiang Zhang, PhD

Baylor College of Medicine